Baxter follows the rigorous US Food and Drug Administration (FDA) and European Medicines Agency (EMEA) policies and criteria for plasma donation centers. Baxter also voluntarily complies with the Plasma Protein Therapeutics Association (PPTA), PPTA’s International Quality Plasma Program (IQPP), Occupational Safety and Health Administration (OSHA), and Clinical Laboratory Improvement Amendment (CLIA) standards to safeguard the collection of plasma used for plasma-derived therapies.
Ready-to-use 10% sterile, liquid preparation
Read More [+]
Sterile, stable, lyophilized preparation of purified alpha 1-proteinase inhibitor
Read More [+]
A comprehensive portfolio of Ig products for all treatment settings - hospital, outpatient, clinic, and home.
Please consult your local approved product labeling for prescribing information. Please note that not all products are licensed in all countries.